BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ·Healthcare·Biotechnology
$8.44
+4.07%
Mkt Cap $1.95B
Analyst Ratings
Buy
8
Hold
1
Sell
0
Price Target (16 analysts)
$19.00
Range $11.00 – $29.00
Implied Upside
+125.3%
Consensus $19.00 vs current $8.44
NASDAQ·Healthcare·Biotechnology
$8.44
+4.07%
Mkt Cap $1.95B
Buy
8
Hold
1
Sell
0
Price Target (16 analysts)
$19.00
Range $11.00 – $29.00
+125.3%
Consensus $19.00 vs current $8.44